Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2026-03-09 @ 8:18 AM
Study NCT ID:
NCT00662818
Status:
COMPLETED
Last Update Posted:
2018-10-19
First Post:
2008-04-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-03-17
Start Date Type:
ACTUAL
Primary Completion Date:
2009-09-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-09-02
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-17
First Submit QC Date:
None
Study First Post Date:
2008-04-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-09-05
Results First Submit QC Date:
None
Results First Post Date:
2014-09-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-18
Last Update Post Date:
2018-10-19
Last Update Post Date Type:
ACTUAL